Literature DB >> 21704289

Comparison of risk scores to estimate perioperative mortality in aortic valve replacement surgery.

Jagroop Basraon1, Yellapragada S Chandrashekhar, Ranjit John, Adheesh Agnihotri, Rosemary Kelly, Herbert Ward, Selcuk Adabag.   

Abstract

BACKGROUND: Transaortic valve implantation has recently been introduced as an alternative to aortic valve replacement (AVR) for high-risk patients with aortic stenosis. However, accurate assessment of surgical risk is critical for appropriate patient selection. We compared the accuracy of The Society of Thoracic Surgeons (STS) risk score, the European System for Cardiac Risk Evaluation (EuroSCORE), and the Veterans Administration (VA) risk score in predicting perioperative mortality after AVR.
METHODS: We included 537 consecutive patients who underwent AVR for severe aortic stenosis at the Minneapolis VA Medical Center between 1997 and 2008. Observed and predicted perioperative (30-day) mortality rates were compared. Hosmer-Lemeshow goodness-of-fit test and receiver operating characteristic curves were performed to assess the performance of the scores.
RESULTS: Perioperative mortality rate was 5.9% (n=32). Predicted mortality rates for the EuroSCORE, STS score, and VA score were 15.6%, 3.6%, and 6.7%, respectively (p=0.001). The EuroSCORE overestimated mortality in all patients, most notably among those with ejection fraction less than 35% (49% predicted versus 9% observed). The EuroSCORE had poor calibration (goodness-of-fit test p<0.008), whereas the STS and the VA scores were well calibrated. However, all three scores displayed good discrimination characteristics per the areas under the receiver operating characteristic curves: STS score 0.73 (95% confidence interval: 0.69 to 0.77); VA score 0.66 (95% confidence interval: 0.62 to 0.70); and EuroSCORE 0.68 (95% confidence interval: 0.64 to 0.72; p>0.05).
CONCLUSIONS: The EuroSCORE substantially overestimates perioperative mortality risk in AVR, particularly in patients with low ejection fraction. These data have implications when deciding the appropriate intervention (transaortic valve implantation versus AVR) for high-risk aortic stenosis patients.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21704289     DOI: 10.1016/j.athoracsur.2011.04.006

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Performance of EuroSCORE II compared to EuroSCORE I in predicting operative and mid-term mortality of patients from a single center after combined coronary artery bypass grafting and aortic valve replacement.

Authors:  Kyriakos Spiliopoulos; Vasilis Bagiatis; Oliver Deutsch; Bernhard M Kemkes; Nikolaos Antonopoulos; Dimos Karangelis; Ayman Haschemi; Brigitte Gansera
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-08-29

2.  Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.

Authors:  Santiago Garcia; Rosemary Kelly; Mackenzie Mbai; Sergey Gurevich; Brett Oestreich; Demetris Yannopoulos; Selcuk Adabag
Journal:  Catheter Cardiovasc Interv       Date:  2018-01-09       Impact factor: 2.692

3.  Variation of mortality after coronary artery bypass surgery in relation to hour, day and month of the procedure.

Authors:  Ann Coumbe; Ranjit John; Michael Kuskowski; Mehmet Agirbasli; Edward O McFalls; Selcuk Adabag
Journal:  BMC Cardiovasc Disord       Date:  2011-10-20       Impact factor: 2.298

4.  Cardiac operative risk evaluation: The EuroSCORE II, does it make a real difference?

Authors:  L Noyez; P C Kievit; H A van Swieten; M-J de Boer
Journal:  Neth Heart J       Date:  2012-12       Impact factor: 2.380

5.  Medium and long-term prognosis of transcatheter aortic valve implantation from the perspective of left ventricular diastolic function.

Authors:  Satoru Kayama; Shungo Aratake; Shegehito Sawamura; Yusuke Watanabe; Ken Kozuma
Journal:  Cardiol J       Date:  2018-03-23       Impact factor: 2.737

6.  Staged balloon aortic valvuloplasty before standard aortic valve replacement in selected patients with severe aortic valve stenosis.

Authors:  Salah Eldien Altarabsheh; Kevin L Greason; Hartzell V Schaff; Rakesh M Suri; Zhuo Li; Verghese Mathew; Lyle D Joyce; Soon J Park; Joseph A Dearani
Journal:  Tex Heart Inst J       Date:  2014-04-01

7.  Left ventricular performance after aortic valve replacement in patients with low ejection fraction.

Authors:  Yoshihisa Tanoue; Yasuhisa Oishi; Hiromichi Sonoda; Takahiro Nishida; Atsuhiro Nakashima; Ryuji Tominaga
Journal:  J Artif Organs       Date:  2013-09-15       Impact factor: 1.731

8.  Validation of EuroSCORE II on a single-centre 3800 patient cohort.

Authors:  Manuel Carnero-Alcázar; Jacobo Alberto Silva Guisasola; Fernando José Reguillo Lacruz; Luis Carlos Maroto Castellanos; Javier Cobiella Carnicer; Enrique Villagrán Medinilla; Teresa Tejerina Sánchez; José Enrique Rodríguez Hernández
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-23

9.  ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement.

Authors:  Giovanni Pulignano; Michele Massimo Gulizia; Samuele Baldasseroni; Francesco Bedogni; Giovanni Cioffi; Ciro Indolfi; Francesco Romeo; Adriano Murrone; Francesco Musumeci; Alessandro Parolari; Leonardo Patanè; Paolo Giuseppe Pino; Annalisa Mongiardo; Carmen Spaccarotella; Roberto Di Bartolomeo; Giuseppe Musumeci
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

10.  Major themes for 2012 in cardiovascular anesthesia and intensive care.

Authors:  H Riha; P Patel; L Al-Ghofaily; E Valentine; A Sophocles; J G T Augoustides
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.